Compromised cell competition exhausts neural stem cells pool

Abstract

Blood vessels play a crucial role in maintaining the stem cell niche in both tumours and developing organs. Cell competition is critical for tumour progression. We hypothesise that blood vessels may act as a regulator of this process. As a pioneer, the secretions of blood vessels regulate the intensity of cell competition, which is essential for tumour invasion and developmental organ extension. Brd4 expresses highly in endothelial cells within various tumours and is positively correlated with numerous invasive genes, making it an ideal focal point for further research on the relationship between blood vessels and cell competition. Our results indicated that the absence of endothelial Brd4 led to a reduction in neural stem cell mortality and compromised cell competition. Endothelial Brd4 regulated cell competition was dependent on Testican2. Testican2 was capable of depositing Sparc and acted as a suppressor of Sparc. Compromised cell competition resulted in the depletion of neural stem cells and accelerated brain ageing. Testican2 could rescue the run-off of neural stem cells and accelerate the turnover rate of neurons. AD patients show compromised cell competition. Through the cloning of a point mutant of Brd4 identified in a subset of AD patients, it was demonstrated that the mutant lacked the ability to promote cell competition. This study suggests a novel approach for treating age-related diseases by enhancing the intensity of cell competition.

References

[1] MadanE, PelhamCJ, NaganeM, et al. Flower isoforms promote competitive growth in cancer. Nature. 2019; 572(7768):260-264.

[2] MorenoE, BaslerK. dMyc transforms cells into super-competitors. Cell. 2004; 117(1):117-129.

[3] WagstaffL, Kolahgar G, PiddiniE. Competitive cell interactions in cancer: a cellular tug of war. Trends Cell Biol. 2013; 23(4):160-167.

[4] MorataG, RipollP. Minutes: mutants of drosophila autonomously affecting cell division rate. Dev Biol. 1975; 42(2):211-221.

[5] SimpsonP, MorataG. Differential mitotic rates and patterns of growth in compartments in the drosophila wing. Dev Biol. 1981; 85(2):299-308.

[6] RhinerC, Lopez-Gay JM, SoldiniD, et al. Flower forms an extracellular code that reveals the fitness of a cell to its neighbors in Drosophila. Dev Cell. 2010; 18(6):985-998.

[7] MerinoMM, RhinerC, PortelaM, Moreno E. "Fitness fingerprints" mediate physiological culling of unwanted neurons in drosophila. Curr Biol. 2013; 23(14):1300-1309.

[8] MorenoE, Fernandez-Marrero Y, MeyerP, RhinerC. Brain regeneration in drosophila involves comparison of neuronal fitness. Curr Biol. 2015; 25(7):955-963.

[9] SunXL, ChenZH, GuoX, et al. Stem cell competition driven by the Axin2-p53 axis controls brain size during murine development. Dev Cell. 2023; 58:744-759.e11.

[10] MerinoMM, RhinerC, Lopez-GayJM, Buechel D, HauertB, MorenoE. Elimination of unfit cells maintains tissue health and prolongs lifespan. Cell. 2015; 160(3):461-476.

[11] CalabreseC, Poppleton H, KocakM, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007; 11(1):69-82.

[12] KarrasP, BordeuI, PozniakJ, et al. A cellular hierarchy in melanoma uncouples growth and metastasis. Nature. 2022; 610(7930):190-198.

[13] TavazoieM, Van der Veken L, Silva-VargasV, et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell. 2008; 3(3):279-288.

[14] DevaiahBN, LewisBA, ChermanN, et al. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci USA. 2012; 109(18):6927-6932.

[15] JangMK, Mochizuki K, ZhouM, JeongHS, BradyJN, OzatoK. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell. 2005; 19(4):523-534.

[16] WangR, LiQ, HelferCM, Jiao J, YouJ. Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure. J Biol Chem. 2012; 287(14):10738-10752.

[17] WuSY, LeeAY, LaiHT, Zhang H, ChiangCM. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell. 2013; 49(5):843-857.

[18] YangZ, YikJH, ChenR, et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005; 19(4):535-545.

[19] BarattaMG, Schinzel AC, ZwangY, et al. An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma. Proc Natl Acad Sci USA. 2015; 112(1):232-237.

[20] DawsonMA, Prinjha RK, DittmannA, et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature. 2011; 478(7370):529-533.

[21] FilippakopoulosP, Qi J, PicaudS, et al. Selective inhibition of BET bromodomains. Nature. 2010; 468(7327):1067-1073.

[22] ZuberJ, ShiJ, WangE, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011; 478(7370):524-528.

[23] DuanQ, WuP, LiuZ, et al. BET bromodomain inhibition suppresses adipogenesis in mice. Endocrine. 2020; 67(1):264-267.

[24] SaitoT. In vivo electroporation in the embryonic mouse central nervous system. Nat Protoc. 2006; 1(3):1552-1558.

[25] WangW, SuL, WangY, Li C, JiF, JiaoJ. Endothelial cells mediated by UCP2 control the neurogenic-to-Astrogenic neural stem cells fate switch during brain development. Adv Sci (Weinh). 2022; 9(18):e2105208.

[26] ZhangM, SuL, WangW, et al. Endothelial cells regulated by RNF20 orchestrate the proliferation and differentiation of neural precursor cells during embryonic development. Cell Rep. 2022; 40(11):111350.

[27] GinistyA, Gely-Pernot A, AbaamraneL, et al. Evidence for a subventricular zone neural stem cell phagocytic activity stimulated by the vitamin K-dependent factor protein S. Stem Cells. 2015; 33(2):515-525.

[28] BradshawAD. Diverse biological functions of the SPARC family of proteins. Int J Biochem Cell Biol. 2012; 44(3):480-488.

[29] PedrosaR, Wismans LV, SinkeR, et al. Differential expression of BOC, SPOCK2, and GJD3 is associated with brain metastasis of ER-negative breast cancers. Cancers (Basel). 2021; 13(12):2982.

[30] RenF, WangD, WangY, Chen P, GuoC. SPOCK2 affects the biological behavior of endometrial cancer cells by regulation of MT1-MMP and MMP2. Reprod Sci. 2020; 27(7):1391-1399.

[31] AhnN, KimWJ, KimN, ParkHW, LeeSW, Yoo JY. The interferon-inducible proteoglycan testican-2/SPOCK2 functions as a protective barrier against virus infection of lung epithelial cells. J Virol. 2019; 93(20):e00662-19.

[32] ZhaoJ, ChengM, GaiJ, ZhangR, DuT, LiQ. SPOCK2 serves as a potential prognostic marker and correlates with immune infiltration in lung adenocarcinoma. Front Genet. 2020; 11:588499.

[33] SchneppA, Komp Lindgren P, HulsmannH, KrogerS, Paulsson M, HartmannU. Mouse testican-2. Expression, glycosylation, and effects on neurite outgrowth. J Biol Chem. 2005; 280(12):11274-11280.

[34] NakadaM, Miyamori H, YamashitaJ, SatoH. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins. Cancer Res. 2003; 63(12):3364-3369.

[35] PortelaM, Casas-Tinto S, RhinerC, et al. Drosophila SPARC is a self-protective signal expressed by loser cells during cell competition. Dev Cell. 2010; 19(4):562-573.

[36] AlbrechtD, Lopez-Murcia FJ, Perez-GonzalezAP, LichtnerG, Solsona C, LlobetA. SPARC prevents maturation of cholinergic presynaptic terminals. Mol Cell Neurosci. 2012; 49(3):364-374.

[37] JonesEV, Bernardinelli Y, TseYC, ChierziS, WongTP, MuraiKK. Astrocytes control glutamate receptor levels at developing synapses through SPARC-beta-integrin interactions. J Neurosci. 2011; 31(11):4154-4165.

[38] KucukdereliH, AllenNJ, LeeAT, et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci USA. 2011; 108(32): E440-E449.

[39] RamirezJJ, BinduDS, ErogluC. Building and destroying synaptic bridges: how do Hevin/Sparcl1, SPARC, and MDGAs modify trans-synaptic neurexin-neuroligin interactions? Structure. 2021; 29(7):635-637.

[40] XieY, KuanAT, WangW, et al. Astrocyte-neuron crosstalk through hedgehog signaling mediates cortical synapse development. Cell Rep. 2022; 38(8):110416.

[41] AuE, Richter MW, VincentAJ, et al. SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J Neurosci. 2007; 27(27):7208-7221.

[42] CampolongoM, Benedetti L, PodhajcerOL, PitossiF, DepinoAM. Hippocampal SPARC regulates depression-related behavior. Genes Brain Behav. 2012; 11(8):966-976.

[43] Rodrigues-AmorimD, Rivera-Baltanas T, Fernandez-PalleiroP, et al. Changes in the brain extracellular matrix composition in schizophrenia: a pathophysiological dysregulation and a potential therapeutic target. Cell Mol Neurobiol. 2022; 42(6):1921-1932.

[44] ZhouY, SuY, LiS, et al. Molecular landscapes of human hippocampal immature neurons across lifespan. Nature. 2022; 607:527-533.

[45] CoelhoDS, Schwartz S, MerinoMM, et al. Culling less fit neurons protects against amyloid-beta-induced brain damage and cognitive and motor decline. Cell Rep. 2018; 25(13):3661-3673 e3663.

[46] JickH, Zornberg GL, JickSS, SeshadriS, Drachman DA. Statins and the risk of dementia. Lancet. 2000; 356(9242):1627-1631.

[47] SparksDL, Sabbagh MN, ConnorDJ, et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005; 62(5):753-757.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.